tiprankstipranks
Trending News
More News >
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Income Statement

Compare
14 Followers

NATCO Pharma Limited Income Statement

Last quarter (Q1 2026), NATCO Pharma Limited's total revenue was ₹13.29B, a decrease of -2.47% from the same quarter last year. In Q1, NATCO Pharma Limited's net income was ₹4.81B. See NATCO Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 44.32B₹ 40.02B₹ 27.09B₹ 19.46B₹ 20.56B
Gross Profit
₹ 37.05B₹ 32.53B₹ 20.54B₹ 13.62B₹ 15.24B
Operating Expenses
₹ 7.04B₹ 6.57B₹ 5.63B₹ 6.69B₹ 5.93B
Depreciation and Amortization
₹ 1.78B₹ 1.80B₹ 1.57B₹ 1.37B₹ 1.13B
EBITDA
₹ 21.44B₹ 17.51B₹ 9.67B₹ 2.60B₹ 6.07B
Operating Income
₹ 30.00B₹ 25.96B₹ 14.92B₹ 6.93B₹ 9.31B
Other Income/Expenses
₹ -7.09B₹ -9.23B₹ -6.30B₹ -4.91B₹ -3.52B
Pretax Income
₹ 22.91B₹ 16.73B₹ 8.62B₹ 2.02B₹ 5.80B
Net Income
₹ 18.85B₹ 13.88B₹ 7.15B₹ 1.70B₹ 4.41B
Per Share Metrics
Basic EPS
₹ 105.26₹ 77.34₹ 39.18₹ 9.32₹ 24.20
Diluted EPS
₹ 105.26₹ 77.34₹ 39.18₹ 9.32₹ 24.16
Weighted Average Shares Outstanding
179.12M 179.51M 182.57M 182.40M 182.49M
Weighted Average Shares Outstanding (Diluted)
179.11M 179.50M 182.55M 182.41M 182.49M
Currency in INR

NATCO Pharma Limited Earnings and Revenue History